Logo image of CYR.DE

CYAN AG (CYR.DE) Stock Fundamental Analysis

FRA:CYR - Deutsche Boerse Ag - DE000A2E4SV8 - Common Stock - Currency: EUR

2.78  0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CYR. CYR was compared to 101 industry peers in the Software industry. While CYR seems to be doing ok healthwise, there are quite some concerns on its profitability. CYR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CYR has reported negative net income.
CYR had a negative operating cash flow in the past year.
CYR had negative earnings in 4 of the past 5 years.
In the past 5 years CYR always reported negative operating cash flow.
CYR.DE Yearly Net Income VS EBIT VS OCF VS FCFCYR.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 5M -5M -10M -15M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -44.07%, CYR is doing worse than 82.83% of the companies in the same industry.
CYR has a worse Return On Equity (-51.15%) than 75.76% of its industry peers.
Industry RankSector Rank
ROA -44.07%
ROE -51.15%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CYR.DE Yearly ROA, ROE, ROICCYR.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 5 -5 -10 -15 -20

1.3 Margins

Looking at the Gross Margin, with a value of 128.90%, CYR belongs to the top of the industry, outperforming 98.99% of the companies in the same industry.
CYR's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for CYR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 128.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.43%
GM growth 5Y-1.01%
CYR.DE Yearly Profit, Operating, Gross MarginsCYR.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

More info and screens

6

2. Health

2.1 Basic Checks

CYR does not have a ROIC to compare to the WACC, probably because it is not profitable.
CYR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CYR.DE Yearly Shares OutstandingCYR.DE Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 5M 10M 15M
CYR.DE Yearly Total Debt VS Total AssetsCYR.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 8.42 indicates that CYR is not in any danger for bankruptcy at the moment.
CYR has a Altman-Z score of 8.42. This is amongst the best in the industry. CYR outperforms 83.84% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that CYR is not too dependend on debt financing.
CYR has a Debt to Equity ratio of 0.06. This is in the better half of the industry: CYR outperforms 79.80% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 8.42
ROIC/WACCN/A
WACC7.4%
CYR.DE Yearly LT Debt VS Equity VS FCFCYR.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 2.17 indicates that CYR has no problem at all paying its short term obligations.
CYR has a better Current ratio (2.17) than 80.81% of its industry peers.
CYR has a Quick Ratio of 2.17. This indicates that CYR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.17, CYR belongs to the top of the industry, outperforming 80.81% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.17
Quick Ratio 2.17
CYR.DE Yearly Current Assets VS Current LiabilitesCYR.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 43.40% over the past year.
Looking at the last year, CYR shows a very negative growth in Revenue. The Revenue has decreased by -29.06% in the last year.
The Revenue for CYR have been decreasing by -11.82% on average. This is quite bad
EPS 1Y (TTM)43.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.58%
Revenue 1Y (TTM)-29.06%
Revenue growth 3Y-39.5%
Revenue growth 5Y-11.82%
Sales Q2Q%55.54%

3.2 Future

Based on estimates for the next years, CYR will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.24% on average per year.
Based on estimates for the next years, CYR will show a very strong growth in Revenue. The Revenue will grow by 22.68% on average per year.
EPS Next Y80.58%
EPS Next 2Y40.66%
EPS Next 3Y29.23%
EPS Next 5Y19.24%
Revenue Next Year-19.32%
Revenue Next 2Y12.82%
Revenue Next 3Y19.32%
Revenue Next 5Y22.68%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CYR.DE Yearly Revenue VS EstimatesCYR.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 10M 20M 30M 40M
CYR.DE Yearly EPS VS EstimatesCYR.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.5 -0.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CYR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CYR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CYR.DE Price Earnings VS Forward Price EarningsCYR.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CYR is valued a bit more expensive than the industry average as 62.63% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 168.18
CYR.DE Per share dataCYR.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

A more expensive valuation may be justified as CYR's earnings are expected to grow with 29.23% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.66%
EPS Next 3Y29.23%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CYR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CYAN AG

FRA:CYR (3/6/2025, 7:00:00 PM)

2.78

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)09-26 2024-09-26
Earnings (Next)05-15 2025-05-15/amc
Inst Owners1.84%
Inst Owner ChangeN/A
Ins Owners36.92%
Ins Owner ChangeN/A
Market Cap56.13M
Analysts80
Price Target3.1 (11.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.49
P/FCF N/A
P/OCF N/A
P/B 1.89
P/tB 20.57
EV/EBITDA 168.18
EPS(TTM)-0.75
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0.21
BVpS1.47
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -44.07%
ROE -51.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 128.9%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.43%
GM growth 5Y-1.01%
F-Score5
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA 5.55
Cap/Depr 19.98%
Cap/Sales 8.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.17
Quick Ratio 2.17
Altman-Z 8.42
F-Score5
WACC7.4%
ROIC/WACCN/A
Cap/Depr(3y)18.02%
Cap/Depr(5y)16.39%
Cap/Sales(3y)13.71%
Cap/Sales(5y)9.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.58%
EPS Next Y80.58%
EPS Next 2Y40.66%
EPS Next 3Y29.23%
EPS Next 5Y19.24%
Revenue 1Y (TTM)-29.06%
Revenue growth 3Y-39.5%
Revenue growth 5Y-11.82%
Sales Q2Q%55.54%
Revenue Next Year-19.32%
Revenue Next 2Y12.82%
Revenue Next 3Y19.32%
Revenue Next 5Y22.68%
EBIT growth 1Y86.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year92.83%
EBIT Next 3Y32.33%
EBIT Next 5Y21.02%
FCF growth 1Y71.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y73.74%
OCF growth 3YN/A
OCF growth 5YN/A